文献速递妇科

早期宫颈癌仅行前哨淋巴结活检后的长期随访

Long-term follow up after sentinel node biopsy alone for early-stage cervical cancer.
PubMed 文献 · Gynecol Oncol · 2022-02-10

本研究对2009至2017年间181例早期宫颈癌患者在子宫切除术或宫颈切除术中行前哨淋巴结活检(SNB),术中若前哨淋巴结阴性则不再切除其他淋巴结。中位随访83.5个月,4例(2.2%)复发,5年无进展生存率和总生存率分别为98.8%和99.4%,术后淋巴水肿等并发症发生率很低。作者认为SNB可能安全有效,未增加复发和术后并发症。

要点

  • 181例早期宫颈癌患者行SNB,中位随访83.5个月,4例(2.2%)复发。
  • 5年无进展生存率和总生存率分别为98.8%和99.4%。
  • 术后淋巴水肿等并发症发生率很低。

核心结论

  • 作者认为,对早期宫颈癌行SNB可能安全有效,未增加复发率和术后并发症发生率。

研究设计与样本

  • 单臂研究,2009至2017年间对181例早期宫颈癌患者在子宫切除术或宫颈切除术中采用放射性同位素法行SNB,术中前哨淋巴结阴性者不再切除其他淋巴结。

主要发现

  • 患者中位年龄34岁(范围21-73岁),FIGO 2008分期IA1期6例、IA2期18例、IB1期154例、IIA1期3例。
  • 181例中44例行子宫切除术、137例行宫颈切除术;8例因术中诊断假阴性未行盆腔淋巴结清扫,20例术后接受辅助治疗。
  • 中位随访83.5个月(范围25-145个月),4例(2.2%)复发,其中盆腔、肺、骨各1例,另1例为盆腔及腹主动脉旁淋巴结转移。
  • 4例复发患者中1例死亡,其余3例经多学科治疗后无病生存。
  • 5年无进展生存率和总生存率分别为98.8%和99.4%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sentinel node biopsy alone (SNB) reduces the postoperative complications of pelvic lymphadenectomy, such as lymphedema and lymphangitis; however, the long-term prognosis after SNB is unclear. The objective of this study was to evaluate the long-term outcome and complications of patients with early-stage cervical cancer who underwent SNB for hysterectomy or trachelectomy. METHODS: We performed SNB for cervical cancer using a radioisotope method in 181 patients between 2009 and 2017. If the intraoperative sentinel lymph node evaluation was negative for metastasis, no further lymph nodes were removed. RESULTS: The median age of the patients was 34 years (range, 21-73 years). The International Federation of Gynecology and Obstetrics 2008 stage was IA1 in 6 patients, IA2 in 18, IB1 in 154, and IIA1 in 3. Of the 181 patients (44 with hysterectomy, 137 with trachelectomy), 8 did not undergo pelvic lymphadenectomy because of a false-negative intraoperative diagnosis, 20 received adjuvant therapy after surgery, and 4 (2.2%) experienced recurrence over a median follow-up period of 83.5 months (range, 25-145 months). In the four recurrent cases, recurrence occurred in the pelvis, lung, and bone in one patient each, while the remaining patient developed pelvic and para-aortic lymph node metastases. Of these four patients, one died, and the remaining three are alive without disease after multidisciplinary therapy. The 5-year progression-free and overall survival rates were 98.8% and 99.4%, respectively. Postoperative complications, such as lymphedema, were very low rate. CONCLUSIONS: SNB for early-stage cervical cancer might be safe and effective, with no increase in the recurrence and postoperative complications rate.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Yahata H, Kodama K, Okugawa K, et al. Long-term follow up after sentinel node biopsy alone for early-stage cervical cancer. Gynecol Oncol. 2022. PMID: 35151491. doi:10.1016/j.ygyno.2022.01.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。